Rare disease tech company was rolled up two years ago. Now it's spinning out again as an independent

This article originally appeared in the San Francisco Business Times, an American City Business Journals sister publication of Bizwomen. Ciitizen, a Palo Alto, California company at the center of helping rare-disease patients collect vital medical records to jumpstart research into those conditions, is spinning out of genetic testing firm Invitae Corp. San Francisco-based Invitae (NYSE: NVTA) bought Ciitizen only two years ago, hoping to tap the startup's expertise in collecting, organizing and …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news